| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.07. | Modular Medical reicht Software-Verbesserungen für Pivot-System bei FDA ein | 2 | Investing.com Deutsch | ||
| 01.07. | Modular Medical, Inc.: Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements | 209 | ACCESS Newswire | Submission Covers Software Enhancements for Patient Flexibility and Customization of Pivot SAN DIEGO, CA / ACCESS Newswire / July 1, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company")... ► Artikel lesen | |
| 30.06. | Modular Medical startet kommerzielle Einführung seiner Insulinpumpe | 5 | Investing.com Deutsch | ||
| 30.06. | Modular Medical begins commercial insulin pump deployment | 2 | Investing.com | ||
| 30.06. | Modular Medical, Inc.: Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump | 327 | ACCESS Newswire | First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial CompanyPivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insulin-Dependent... ► Artikel lesen | |
| 30.06. | EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump | 2 | Benzinga.com | ||
| 29.06. | Modular Medical, Inc. - 10-K, Annual Report | 5 | SEC Filings | ||
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| 26.06. | Modular Medical begins shipping Pivot insulin pump to doctors | 1 | Investing.com | ||
| 26.06. | Modular Medical, Inc.: Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps | 254 | ACCESS Newswire | Pivot starter kits are now shipping to multiple endocrinology practices SAN DIEGO, CA / ACCESS Newswire / June 26, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a... ► Artikel lesen | |
| 24.06. | Modular Medical launches Pivot tubeless insulin patch pump | 1 | MassDevice | ||
| 24.06. | Modular Medical, Inc.: Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion | 341 | ACCESS Newswire | The Pivot tubeless insulin patch pump is now commercially available in the U.S. following FDA 510(k) clearance in AprilPivot represents a differentiated solution for insulin-dependent adults still on... ► Artikel lesen | |
| 24.06. | EXCLUSIVE: Modular Medical Transitions To Commercial Stage With Pivot Insulin Pump Launch | 2 | Benzinga.com | ||
| 04.06. | Modular Medical, Inc.: Modular Medical Launches New Website for Pivot Tubeless Insulin Patch Pump | 301 | ACCESS Newswire | Initial patients expected in June 2026 SAN DIEGO, CA / ACCESS Newswire / June 4, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric... ► Artikel lesen | |
| 20.05. | Modular Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.04. | Modular Medical, Inc.: Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026 | 379 | ACCESS Newswire | Meet with Modular Medical CEO Jeb BesserThere are 4.8 million individuals with diabetes in the US that require daily insulin. Only 20% currently use an insulin pump.Discover Modular Medical's Pivot... ► Artikel lesen | |
| 20.04. | Modular Medical prices $3.4M offering at $4.50 per share | 2 | Seeking Alpha | ||
| 20.04. | Modular Medical platziert Kapitalerhöhung über 3,4 Mio. US-Dollar mit deutlichem Abschlag | 3 | Investing.com Deutsch | ||
| 20.04. | Modular Medical prices $3.4 million stock offering at $4.50/share | 2 | Investing.com | ||
| 20.04. | Modular Medical, Inc.: Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock | 534 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / April 19, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced... ► Artikel lesen | |
| 16.04. | Modular Medical erfüllt wieder Mindestkursanforderung der NASDAQ | 9 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,466 | -0,21 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| LIFEWARD | 8,100 | -5,15 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| IMUNON | 1,730 | -4,95 % | Celsion Bank wird Mitglied des Liechtensteinischen Bankenverbandes | Vaduz - Die Celsion Bank AG ist seit 1. Juli 2026 Vollmitglied des Liechtensteinischen Bankenverbandes (LBV). Die Celsion Bank bringt ein klares Profil mit Fokus auf digitale Vermögenswerte ein und... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 42,800 | -0,93 % | Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026 | ||
| INSPIREMD | 0,610 | -1,61 % | InspireMD, Inc. - 8-K, Current Report | ||
| GT BIOPHARMA | 0,466 | -0,32 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| MYOMO | 1,008 | +3,28 % | MYOMO, INC. - 8-K, Current Report | ||
| INOGEN | 5,750 | +0,88 % | Inogen appoints Andy Reding as chief operating officer | ||
| INTELLIGENT BIO SOLUTIONS | 2,140 | -1,38 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,610 | +0,83 % | Lexaria Bioscience Corp.: Lexaria Updates Business Development | KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,360 | -0,59 % | Incannex Healthcare: Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea | MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| GLUCOTRACK | 0,357 | -2,57 % | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| LENSAR | 6,100 | +1,67 % | LENSAR, Inc.: LENSAR Reports First Quarter 2026 Results and Provides Business Update | 7 ALLY Robotic Cataract Laser Systems® ("ALLY System") Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser... ► Artikel lesen | |
| HEARTBEAM | 0,625 | -0,06 % | HeartBeam, Inc. - 8-K, Current Report | ||
| JIN MEDICAL INTERNATIONAL | 1,900 | -0,52 % | Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement | CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen |